In gastric cancer, gelsolin decreased EMT through inhibition of p38 signaling [80], while in bladder cancer gelsolin promoted carcinogenesis by inactivating the Hippo pathway leading to the nuclear translocation of Yes-associated protein [81]. The gene discussed is GSN; the disease is urinary bladder carcinoma.